Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin

被引:40
|
作者
Bergqvist, D
Lindgren, B
Matzsch, T
机构
[1] UNIV LUND HOSP,DEPT COMMUNITY MED,MALMO,SWEDEN
[2] LUND UNIV,MALMO GEN HOSP,DEPT SURG,LUND,SWEDEN
关键词
D O I
10.1002/bjs.1800831117
中图分类号
R61 [外科手术学];
学科分类号
摘要
The relative costs were analysed of (1) no prophylaxis against deep vein thrombosis (DVT), (2) selective treatment of DVT after confirmation of diagnosis, (3) general prophylaxis with standard low-dose unfractionated heparin and (4) general prophylaxis with low molecular weight heparin (LMWH) in patients undergoing elective general abdominal surgery or elective hip surgery. The mean calculated costs per patient undergoing general abdominal surgery were: Swedish crowns (SEK) 1950 for no prophylaxis, SEK 5710 for selective treatment of DVT, SEK 735 for prophylaxis with unfractionated heparin and SEK 665 for prophylaxis with LMWH. The corresponding costs for hip surgery were SEK 3930, SEK 10 790, SEK 1730 and SEK 1390 respectively. Thus, the least expensive management strategy in patients undergoing elective general abdominal or hip surgery would appear to be general prophylaxis with either unfractionated heparin or LMWH, Furthermore, general prophylaxis with LMWH would appear to be more cost-effective than general prophylaxis with unfractionated heparin.
引用
收藏
页码:1548 / 1552
页数:5
相关论文
共 50 条
  • [21] Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
    Merli, Geno J.
    Kind, Ludwig A.
    American Journal of Physical Medicine and Rehabilitation, 2000, 79 (5 SUPPL.):
  • [22] Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
    Merli, GJ
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2000, 79 (05) : S9 - S16
  • [23] To Compare the Effectiveness of Low-Molecular-Weight Heparin and Unfractionated Heparin in Reducing Lower Limb Girth in Deep Vein Thrombosis
    Ullalkar, Neha
    Vedanth, M.
    Sreeramulu, P. N.
    Vaibhavi, D.
    Shashirekha, C. A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [24] PREVENTION OF DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT - RANDOMIZED COMPARISON BETWEEN UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
    LEYVRAZ, PF
    BACHMANN, F
    HOEK, J
    BULLER, HR
    POSTEL, M
    SAMAMA, M
    VANDENBROEK, MD
    BRITISH MEDICAL JOURNAL, 1991, 303 (6802): : 543 - 548
  • [25] Transaminase elevation in patients with unfractionated heparin or low molecular weight heparin for deep venous thrombosis
    Rossi, L
    Girolami, B
    Villalta, S
    Scarano, L
    Marchiori, A
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1163 - P1163
  • [26] Comparison of unfractionated vs low molecular weight heparin in cerebral venous thrombosis
    Prabhakar, S
    Pandey, AK
    Lal, V
    Das, CP
    Kharbanda, PS
    Modi, M
    Khurana, D
    STROKE, 2004, 35 (06) : E241 - E241
  • [27] Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis
    Belcaro, G
    Nicolaides, AN
    Cesarone, MR
    Laurora, G
    De Sanctis, MT
    Incandela, L
    Barsotti, A
    Corsi, M
    Vasdekis, S
    Christopoulos, D
    Lennox, A
    Malouf, M
    ANGIOLOGY, 1999, 50 (10) : 781 - 787
  • [28] Tinzaparin, a low molecular weight heparin for treatment of deep vein thrombosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1098): : 14 - 15
  • [29] Overdose of low molecular weight heparin in a patient with deep vein thrombosis
    Geuenich, S
    Pihusch, R
    Göhring, P
    Pihusch, M
    Salat, C
    Hiller, E
    THROMBOSIS AND HAEMOSTASIS, 1999, : 861 - 862
  • [30] Low-molecular-weight heparin for the treatment of deep vein thrombosis
    Thompson-Ford, JK
    PHARMACOTHERAPY, 1998, 18 (04): : 748 - 758